Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells

Our data support the hypothesis that the anti-tumour effects of paclitaxel may, at least in part, be mediated by the capacity of this drug to modulate the procoagulant potential of cancer and host cells.